Medtronic (MDT) Tops Q3 EPS by 1c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report
February 22, 2017 9:23 AM ESTOppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $84.00) while maintaining a Outperform rating.
Analyst Steven Lichtman commented, "MDT's F3Q sales (+6% cc) came in ahead, with each major segment coming in slightly above our thinking, and growth evenly split... More
Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results
February 22, 2017 7:52 AM ESTWedbush Securities analyst Tao Levy reiterates Neutral rating and $85 price target on Medtronic Plc (NYSE: MDT), suggesting solid results demonstrate recovery from last quarters disruptions, as the company reported fiscal 2017 third quarter revenues above consensus estimates.
Levy comments, "Medtronics broad product portfolio allows the company to... More
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
February 21, 2017 1:38 PM ESTNeedham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $84.00) while maintaining a Buy rating. 3Q revenue was $7.283B vs. consensus estimates of $7.221B and adjusted EPS was $1.12 vs. consensus of $1.11.
Analyst Mike Matson commented, "F3Q17 revenue and... More
Medtronic, Inc. (MDT) PT Raised to $88 at Evercore ISI
February 21, 2017 11:50 AM ESTEvercore ISI raised its price target on Medtronic, Inc. (NYSE: MDT) to $88.00 (from $78.00) while maintaining a Buy rating following results this morning.
Analyst Vijay Kumar commented, "MDT started 2017 with a solid execution, highlighted by all around revenue beat and operating margins that were generally in line with ST (came in above us). The importance of this Q cannot be underestimated in our mind, as sentiment had turned negative (post a disappointing 1H) and the stock... More
